Renaissance Technologies’s Biostage, Inc. Common Stock BSTG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-211,700
| Closed | -$65K | – | 3646 |
|
|
2017
Q3 | $65K | Sell |
211,700
-491,900
| -70% | -$197K | ﹤0.01% | 3116 |
|
|
2017
Q2 | $290K | Buy |
703,600
+83,800
| +14% | +$26.6K | ﹤0.01% | 2913 |
|
|
2017
Q1 | $227K | Buy |
619,800
+369,300
| +147% | +$202K | ﹤0.01% | 2974 |
|
|
2016
Q4 | $223K | Sell |
250,500
-18,100
| -7% | -$16.1K | ﹤0.01% | 2972 |
|
|
2016
Q3 | $290K | Sell |
268,600
-67,800
| -20% | -$73K | ﹤0.01% | 2974 |
|
|
2016
Q2 | $383K | Sell |
336,400
-49,000
| -13% | -$79K | ﹤0.01% | 2877 |
|
|
2016
Q1 | $690K | Sell |
385,400
-8,400
| -2% | -$13.9K | ﹤0.01% | 2736 |
|
|
2015
Q4 | $858K | Buy |
393,800
+238,000
| +153% | +$332K | ﹤0.01% | 2532 |
|
|
2015
Q3 | $132K | Buy |
155,800
+48,799
| +46% | +$55.3K | ﹤0.01% | 2969 |
|
|
2015
Q2 | $153K | Buy |
107,001
+92,101
| +618% | +$226K | ﹤0.01% | 3034 |
|
|
2015
Q1 | $48K | Buy |
+14,900
| New | +$50.8K | ﹤0.01% | 3083 |
|
|
2014
Q1 | – | Sell |
-70,750
| Closed | -$336K | – | 3135 |
|
|
2013
Q4 | $336K | Buy |
+70,750
| New | +$331K | ﹤0.01% | 2479 |
|
Renaissance Technologies's BSTG Position: Q4 2017 in Review
Renaissance Technologies sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 211,700 shares — an estimated $65K sold.
Renaissance Technologies first reported a position in BSTG in Q4 2013 and held it in 12 quarters. The position peaked at $858K in Q4 2015. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.
- Renaissance Technologies reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
- Renaissance Technologies sold 211,700 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $65K.
- Renaissance Technologies first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 12 quarters.
- Renaissance Technologies's Biostage, Inc. Common Stock position peaked at $858K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.